The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
Cell Death & Disease, Published online: 16 January 2020; doi:10.1038/s41419-020-2225-6The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines
Source: Cell death and disease - Category: Internal Medicine Authors: Minle Li Xuping Zhang Ying Lu Sen Meng Haoyu Quan Pingfu Hou Pan Tong Dafei Chai Xiaoge Gao Junnian Zheng Xuemei Tong Jin Bai Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer | Men | Translocation